1.42
前日終値:
$1.50
開ける:
$1.5
24時間の取引高:
24,823
Relative Volume:
1.58
時価総額:
$57.93M
収益:
-
当期純損益:
-
株価収益率:
-0.5636
EPS:
-2.5197
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-3.40%
1か月 パフォーマンス:
-13.94%
6か月 パフォーマンス:
-28.28%
1年 パフォーマンス:
-56.97%
Adlai Nortye Ltd Adr Stock (ANL) Company Profile
ANL を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ANL
Adlai Nortye Ltd Adr
|
1.42 | 57.93M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
459.41 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
538.11 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
324.13 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
546.04 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
240.99 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Adlai Nortye Ltd Adr Stock (ANL) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-06-02 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2024-09-04 | 開始されました | H.C. Wainwright | Buy |
2023-10-24 | 開始されました | Cantor Fitzgerald | Overweight |
Adlai Nortye Ltd Adr (ANL) 最新ニュース
H.C. WAINWRIGHT CUTS ADLAI NORTYE STOCK RATING AFTER TRIAL RESULTS By Investing.com - Investing.com South Africa
H.C. WAINWRIGHT CUTS ADLAI NORTYE STOCK RATING AFTER TRIAL RESULTS - Investing.com
Adlai Nortye Discontinues Buparlisib Development After Phase III Trial Results - TipRanks
ANL stock touches 52-week low at $1.71 amid sharp annual decline - Investing.com India
ANL stock touches 52-week low at $1.71 amid sharp annual decline By Investing.com - Investing.com South Africa
ANL stock touches 52-week low at $1.85 amid sharp annual decline By Investing.com - Investing.com South Africa
ANL stock touches 52-week low at $1.85 amid sharp annual decline - Investing.com India
Adlai Nortye stock hits 52-week low at $1.85 amid sharp decline By Investing.com - Investing.com South Africa
Adlai Nortye stock hits 52-week low at $1.85 amid sharp decline - Investing.com India
Adlai Nortye Announces Change in Auditing Firm - TipRanks
Adlai Nortye Announces CFO Transition with Interim Appointment - TipRanks
Adlai Nortye IPO gives old Novartis cancer drug new life - BioPharma Dive
CRVO Stock Quote Price and Forecast - CNN
Adlai Nortye Ltd Adr (ANL) 財務データ
Adlai Nortye Ltd Adr (ANL) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):